YOLFTbeta
Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc.

INBS · NASDAQ · Healthcare / Medical Devices

1.76USD-0.17 (-8.81%)

Price History

Full chart

Market Stats

Previous Close1.93
Open1.93
Day Range1.70 – 1.97
52-Week Range1.52 – 24.90
Volume68.71K
Market Cap5.47M
P/E (TTM)0.00
Forward P/E0.00
EPS-8.44
Dividend Yield0.00%
Beta4.25
50-Day Avg2.14
200-Day Avg4.06

About

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Harry Simeonidis
  • Employees59
  • Headquarters135 West, 41st Street, New York, NY, United States, 10036, USA
  • Websitehttps://ibs.inc

Leadership

  • Mr. Harry SimeonidisPresident & CEO · b. 1968
  • Mr. Spiro Kevin Sakiris B.Bus, C.A., Dip LawChief Financial Officer · b. 1962
  • Callistus SequeiraVice President of Global Quality & Operations
  • Mr. Doug HeathVice President of Global Sales
  • Anna TurkingtonVice President of Marketing

Financials

Income Statement

Currency: USD2017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue--0188.74K1.98M01.26M3.11M3.05M4.22M
Growth (%)----+949.30%-100.00%-+147.58%-1.90%+38.09%
Cost of Revenue-----0930.20K1.69M1.81M2.17M
Gross Profit---188.74K1.98M0326.67K1.43M1.25M2.05M
Gross Margin---100.00%100.00%-25.99%45.81%40.85%48.63%
Operating Expense---2.89M7.55M8.34M12.92M11.71M11.89M14.66M
Operating Income-173.00K-4.60M-6.73M-2.71M-5.57M-8.34M-12.60M-10.28M-10.64M-12.61M
Operating Margin----1433.70%-281.42%--1002.11%-330.46%-348.71%-299.11%
EBITDA-151.00K-417.00K-6.67M-2.56M-1.82M-8.30M-9.47M-9.05M-9.45M-11.29M
EBITDA Margin----1353.72%-92.05%--753.80%-290.81%-309.72%-267.94%
Net Income-340.00K-5.02M-7.34M-3.71M-7.04M-8.31M-10.63M-10.16M-10.57M-12.43M
Net Income Margin----1967.77%-355.33%--845.89%-326.40%-346.23%-294.91%
R&D-2.53M3.18M588.21K3.84M3.85M507.42K1.67M2.40M3.37M
R&D as % of Total Revenue---311.64%193.68%-40.37%53.79%78.51%79.98%
Interest Expense-453.87K664.84K457.75K1.09M7.54K223.53K167.14K60.89K10.74K
Interest Expense % of Total Revenue---242.52%55.24%-17.78%5.37%1.99%0.25%

Balance Sheet

Currency: USD2017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets667.23K2.50M2.33M2.48M21.86M12.35M10.35M13.78M8.25M11.94M
Total Liabilities6.58M5.56M6.31M7.69M6.85M5.81M6.67M5.60M5.44M6.65M
Total Equity-5.91M-4.38M-4.62M-5.19M15.06M6.55M3.80M8.33M3.00M5.51M
Cash56.03K418.42K197.94K427.27K12.57M8.24M1.54M6.30M1.02M3.99M
Total Debt3.53M4.84M5.13M5.13M--1.92M1.15M281.81K1.82M
Net Debt3.48M4.42M4.93M4.71M-12.57M-8.24M378.05K-5.16M-738.10K-2.17M

Cash Flow

Currency: USD2017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-243.89K-5.38M-5.58M-498.62K-11.30M-3.36M-7.38M-9.57M-9.68M-11.93M
Investing Cash Flow---14.00K-14.00K-880.22K-880.22K-694.14K--231.84K-85.57K
Financing Cash Flow299.92K5.18M5.32M733.86K23.40M1.44M1.44M14.56M4.60M14.98M
Capital Expenditure00380.22K380.22K3380.22K505.12K221.43K231.84K125.73K
Free Cash Flow-243.89K-5.38M-5.58M-498.62K-11.30M-3.74M-7.88M-9.79M-9.91M-12.05M
FCF to OCF100.00%100.00%100.00%100.00%100.00%111.32%106.85%102.31%102.40%101.05%

Earnings

Report DateJul 5, 2019Nov 29, 2019Feb 12, 2021May 13, 2021Sep 15, 2021Nov 12, 2021Feb 10, 2022May 11, 2022Aug 31, 2022Nov 9, 2022Feb 14, 2023May 11, 2023Aug 23, 2023Nov 8, 2023Feb 9, 2024May 8, 2024Sep 19, 2024Nov 7, 2024Feb 13, 2025May 13, 2025Aug 15, 2025Nov 12, 2025Feb 12, 2026May 13, 2026Aug 19, 2026Nov 11, 2026
EPS Estimate0.000.000.000.00---384.00-384.00-432.00-0.10-264.00-328.80-178.80-7.68-32.40-8.70-0.51-0.53-0.27-0.100.08-0.27-0.161.40-1.58-
EPS Actual-0.19-0.09-0.23-0.27-0.07-0.27-552.00-216.00-336.00-0.08-55.20-686.40-229.20-1.04-20.70-14.30-1.34-0.70-0.50-0.44-0.44-0.35-2.82-1.80-0.90-
Surprise-------43.75%43.75%22.22%20.00%79.09%-108.76%-28.19%86.45%36.11%-64.37%-162.75%-32.08%-85.19%-340.00%-650.00%-29.63%-1662.50%-228.57%43.04%-
Timing----After-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-market-------Pre-marketPre-market-

Key Statistics & Ratios

Market Cap5.47M
Enterprise Value3.70M
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.30
Price / Book1.07
EPS-8.44
Book Value1.90
Revenue (TTM)4.22M
Gross Profit (TTM)2.05M
EBITDA-11.15M
Profit Margin-294.91%
Operating Margin-345.98%
Return on Equity-307.69%
Return on Assets-76.20%
Shares Outstanding3.32M
Shares Float2.94M
Beta4.25
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 1 analystsTarget 12.00
  • Strong Buy
    1

Ownership Breakdown

Institutions
5.47%
Insiders
2.73%
Retail / Other
91.80%

Top Institutional Holders

  • Armistice Capital, LLC
    130.00K4.31%
  • Alyeska Investment Group, L.P.
    37.96K1.26%
  • Geode Capital Management, LLC
    28.61K0.95%
  • Vanguard Capital Management, LLC
    5.81K0.19%
  • Vanguard Fiduciary Trust Co
    3.96K0.13%
  • Tower Research Capital LLC
    1.25K0.04%
  • UBS Group AG
    3720.01%
  • Advisor Group Holdings, Inc.
    2000.01%
  • SHP Wealth Management
    00.00%
  • CURIO WEALTH, LLC
    00.00%
  • Citigroup Inc
    00.00%
  • NATIONAL BANK OF CANADA /FI/
    00.00%
  • Bank of America Corp
    00.00%

Top Fund Holders

  • Fidelity Extended Market Index
    12.54K0.41%
  • Fidelity Nasdaq Composite Index
    2.54K0.08%
  • Fidelity Series Total Market Index
    1.77K0.06%
  • Fidelity Total Market Index
    4090.01%

Stock Splits

  • Dec 16, 20251:10
  • Jan 29, 20241:12
  • Feb 10, 20231:20